DRUG bosses must approve a “lifeline” drug for use on the NHS to stop patients losing the power to move, breathe and swallow, a charity has said.
Muscular Dystrophy UK is urging the Scottish Medicines Consortium (SMC) to make Spinraza available to patients with a rare muscle-wasting condition called spinal muscular atrophy (SMA).
The most acute form carries a life expectancy of around two years. More than 100 people in Scotland have some form of SMA and the charity says the drug, which is the only one of its kind, could “buy families time to spend with their loved ones”.
It is currently provided to some young patients in Scotland through a temporary scheme. The SMC will next rule on whether to approve the treatment for use on the NHS.
Ahead of a meeting with officials today, Muscular Dystrophy UK chief executive Robert Meadowcroft said: “Some children who have received Spinraza have seen their muscle strength improve and have already lived long enough to crawl, and even walk. For parents, this is priceless.
“The SMC has a chance to hand patients the lifeline they so desperately need. If they squander this opportunity to bring hope into the lives of people affected by muscle-wasting conditions, families will be made to pay a very heavy price.”
Hayleigh Barclay, from Prestwick in South Ayrshire, said the roll-out would be a “lifeline” for many. The 30-year-old, who has SMA, said: “It’s hard to overstate how much of a lifeline Spinraza would be for many people.
“I’m a very determined, ambitious person with many goals, but having to constantly battle against the effects of SMA severely impacts on your quality of life.”
The SMC said it is “currently reviewing” the issue and a decision will be published on May 7.
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here